Literature DB >> 34862218

Update in the diagnosis and management of acute pulmonary embolism for the non-respiratory physician.

Sheila Ramjug1, Gerrard Phillips2.   

Abstract

An increasingly common scenario on the acute medical take is that of 'possible pulmonary embolism'. The aim of this article is to update the reader about the available clinical decision tools that can help to avoid the over investigation of such patients, as well as other tools that can support an outpatient management strategy in appropriate patient groups. The importance of risk stratification methodologies in acute pulmonary embolism management is emphasised. We address the evidence on the long-term risk of venous thromboembolism recurrence and show how this can be used to make decisions about duration of anticoagulation. Finally, we discuss a number of special scenarios, including the implications of incidentally discovered isolated subsegmental pulmonary embolus and the management of pulmonary embolus in malignancy and pregnancy. © Royal College of Physicians 2021. All rights reserved.

Entities:  

Keywords:  chronic thromboembolic pulmonary hypertension; pulmonary embolism; venous thromboembolism

Mesh:

Substances:

Year:  2021        PMID: 34862218      PMCID: PMC8806288          DOI: 10.7861/clinmed.2021-0666

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  23 in total

1.  Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism.

Authors:  J A Kline; A M Mitchell; C Kabrhel; P B Richman; D M Courtney
Journal:  J Thromb Haemost       Date:  2004-08       Impact factor: 5.824

Review 2.  Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis.

Authors:  Zhu Zhang; Zhen-guo Zhai; Li-rong Liang; Fang-fang Liu; Yuan-hua Yang; Chen Wang
Journal:  Thromb Res       Date:  2013-12-23       Impact factor: 3.944

Review 3.  Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study.

Authors:  Davide Imberti; Fulvio Pomero; Daniela Mastroiacovo
Journal:  Blood Transfus       Date:  2019-04-30       Impact factor: 3.443

4.  Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study.

Authors:  W Zondag; I C M Mos; D Creemers-Schild; A D M Hoogerbrugge; O M Dekkers; J Dolsma; M Eijsvogel; L M Faber; H M A Hofstee; M M C Hovens; G J P M Jonkers; K W van Kralingen; M J H A Kruip; T Vlasveld; M J M de Vreede; M V Huisman
Journal:  J Thromb Haemost       Date:  2011-08       Impact factor: 5.824

5.  Fibrinolysis for patients with intermediate-risk pulmonary embolism.

Authors:  Guy Meyer; Eric Vicaut; Thierry Danays; Giancarlo Agnelli; Cecilia Becattini; Jan Beyer-Westendorf; Erich Bluhmki; Helene Bouvaist; Benjamin Brenner; Francis Couturaud; Claudia Dellas; Klaus Empen; Ana Franca; Nazzareno Galiè; Annette Geibel; Samuel Z Goldhaber; David Jimenez; Matija Kozak; Christian Kupatt; Nils Kucher; Irene M Lang; Mareike Lankeit; Nicolas Meneveau; Gerard Pacouret; Massimiliano Palazzini; Antoniu Petris; Piotr Pruszczyk; Matteo Rugolotto; Aldo Salvi; Sebastian Schellong; Mustapha Sebbane; Bozena Sobkowicz; Branislav S Stefanovic; Holger Thiele; Adam Torbicki; Franck Verschuren; Stavros V Konstantinides
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

6.  Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis.

Authors:  Ang Li; David A Garcia; Gary H Lyman; Marc Carrier
Journal:  Thromb Res       Date:  2018-03-02       Impact factor: 3.944

Review 7.  ERS statement on chronic thromboembolic pulmonary hypertension.

Authors:  Marion Delcroix; Adam Torbicki; Deepa Gopalan; Olivier Sitbon; Frederikus A Klok; Irene Lang; David Jenkins; Nick H Kim; Marc Humbert; Xavier Jais; Anton Vonk Noordegraaf; Joanna Pepke-Zaba; Philippe Brénot; Peter Dorfmuller; Elie Fadel; Hossein-Ardeschir Ghofrani; Marius M Hoeper; Pavel Jansa; Michael Madani; Hiromi Matsubara; Takeshi Ogo; Ekkehard Grünig; Andrea D'Armini; Nazzareno Galie; Bernhard Meyer; Patrick Corkery; Gergely Meszaros; Eckhard Mayer; Gérald Simonneau
Journal:  Eur Respir J       Date:  2021-06-17       Impact factor: 16.671

8.  Pulmonary embolism rule-out criteria (PERC) rule in European patients with low implicit clinical probability (PERCEPIC): a multicentre, prospective, observational study.

Authors:  Andrea Penaloza; Caroline Soulié; Thomas Moumneh; Quentin Delmez; Alexandre Ghuysen; Dominique El Kouri; Christian Brice; Nicolas S Marjanovic; Jacques Bouget; Fares Moustafa; Albert Trinh-Duc; Catherine Le Gall; Lionel Imsaad; Jean-Marie Chrétien; Béatrice Gable; Philippe Girard; Olivier Sanchez; Jeannot Schmidt; Grégoire Le Gal; Guy Meyer; Nicolas Delvau; Pierre-Marie Roy
Journal:  Lancet Haematol       Date:  2017-11-14       Impact factor: 18.959

9.  Effect of the Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients: The PROPER Randomized Clinical Trial.

Authors:  Yonathan Freund; Marine Cachanado; Adeline Aubry; Charlotte Orsini; Pierre-Alexis Raynal; Anne-Laure Féral-Pierssens; Sandrine Charpentier; Florence Dumas; Nacera Baarir; Jennifer Truchot; Thibaut Desmettre; Karim Tazarourte; Sebastien Beaune; Agathe Leleu; Mehdi Khellaf; Mathias Wargon; Ben Bloom; Alexandra Rousseau; Tabassome Simon; Bruno Riou
Journal:  JAMA       Date:  2018-02-13       Impact factor: 56.272

10.  Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.

Authors:  Marc Righini; Josien Van Es; Paul L Den Exter; Pierre-Marie Roy; Franck Verschuren; Alexandre Ghuysen; Olivier T Rutschmann; Olivier Sanchez; Morgan Jaffrelot; Albert Trinh-Duc; Catherine Le Gall; Farès Moustafa; Alessandra Principe; Anja A Van Houten; Marije Ten Wolde; Renée A Douma; Germa Hazelaar; Petra M G Erkens; Klaas W Van Kralingen; Marco J J H Grootenboers; Marc F Durian; Y Whitney Cheung; Guy Meyer; Henri Bounameaux; Menno V Huisman; Pieter W Kamphuisen; Grégoire Le Gal
Journal:  JAMA       Date:  2014-03-19       Impact factor: 56.272

View more
  1 in total

1.  The association of pleural effusion and pulmonary embolism.

Authors:  Oscar Jolobe
Journal:  Clin Med (Lond)       Date:  2022-03       Impact factor: 5.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.